Example: Heart Attack

Clinical Trials on Glucose Transporter Type 1 Deficiency Syndrome

Total 21 results

    • NCT01993186
      Completed
      Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
      Conditions: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
    • NCT02960217
      Terminated
      Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
      Conditions: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
    • NCT02599961
      Terminated
      Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS)
      Conditions: Glucose Transporter Type 1 Deficiency Syndrome
    • NCT02036853
      Recruiting
      An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
      Conditions: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
    • NCT03773770
      Available
      Expanded Access to Triheptanoin
      Conditions: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
    • NCT02000960
      Unknown status
      Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
      Conditions: Glucose Transporter Type 1 Deficiency Syndrome
    • NCT04137692
      Active, not recruiting
      Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome
      Conditions: Glucose Transporter Type 1 Deficiency Syndrome; GLUT1DS1
    • NCT02018315
      Completed
      Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)
      Conditions: Glucose Transporter Type 1 Deficiency Syndrome; GLUT1 Deficiency Syndrome
    • NCT02021526
      Withdrawn
      Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)
      Conditions: Glucose Transporter Type 1 Deficiency Syndrome; Glut1 Deficiency Syndrome
    • NCT02018302
      No longer available
      Post Study Continuation of C7 for G1D
      Conditions: Glut1 Deficiency Syndrome; Glucose Transporter Type 1 Deficiency Syndrome
    • NCT02014883
      Unknown status
      Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS
      Conditions: Glut1 Deficiency Syndrome
    • NCT02013583
      Recruiting
      The Glucose Transporter Type I Deficiency (G1D) Registry
      Conditions: GLUT1 Deficiency Syndrome; Glucose Transporter Type 1 Deficiency Syndrome; Glucose Transporter type1 (GLUT-1) Deficiency; GLUT-1 Deficiency Syndrome
    • NCT04112862
      Not yet recruiting
      Sodium Lactate Infusion in GLUT1DS Patients
      Conditions: GLUT1 Deficiency Syndrome; GLUT1DS1; GLUT1DS2; Epilepsy; Lactic Acid Blood Increased; Ketogenic Dieting
    • NCT03202108
      Withdrawn
      Evaluation of Krio in Children and Adults With Epilepsy
      Conditions: Ketogenic Dieting; Epilepsy; Glucose Transporter Type 1 Deficiency Syndrome
    • NCT02915211
      Completed
      Evaluation of Keyo in Children With Epilepsy
      Conditions: Intractable Epilepsy; Glucose Transporter Type 1 Deficiency Syndrome; Ketogenic Dieting
    • NCT04399954
      Recruiting
      Evaluation of Ketoflo
      Conditions: Epilepsy Intractable; Glucose Transporter Type 1 Deficiency Syndrome; Ketogenic Dieting
    • NCT03722212
      Recruiting
      Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test
      Conditions: Glut1 Deficiency Syndrome; De Vivo Disease; Seizures; Movement Disorders; Intellectual Disability; Ataxia
    • NCT03301532
      Active, not recruiting
      Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D
      Conditions: GLUT1DS1
    • NCT03181399
      Active, not recruiting
      Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)
      Conditions: GLUT1DS1; Epilepsy; Glut1 Deficiency Syndrome 1, Autosomal Recessive; Glucose Metabolism Disorders; Glucose Transport Defect; Glucose Transporter Type 1 Deficiency Syndrome; Glucose Transporter Protein Type 1 Deficiency Syndrome
    • NCT03041363
      Active, not recruiting
      Treatment Development of Triheptanoin (G1D)
      Conditions: Epilepsy; GLUT1DS1; Glut1 Deficiency Syndrome 1, Autosomal Recessive; Glucose Metabolism Disorders; Glucose Transport Defect; Glucose Transporter Type 1 Deficiency Syndrome; Glucose Transporter Protein Type 1 Deficiency Syndrome
    • NCT02968953
      No longer available
      Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome
      Conditions: Glucose Transporter 1 Deficiency Syndrome
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations